Is KRYS stock safe? | Glauxie AI

Q: Is KRYS stock safe?

Krystal Biotech, Inc. (KRYS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Krish S. Krishnan. Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is... Employees: 105,000.

Q: What are the risks of investing in KRYS?

Identify key risks of investing in KRYS — debt, competition, volatility, and sector headwinds.

Q: Is KRYS a good long-term investment?

Evaluate KRYS as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does KRYS have?

Review KRYS total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is KRYS stock safe?

🦉

Krystal Biotech, Inc. (KRYS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOKrish S. Krishnan

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis...

Key Executives

Name	Title
Christine Wilson	Senior VP & Head of US Commercial
David Chien	Senior Vice President of Clinical Development
David Sweet	Director of Clinical Development
John Karakkal	Vice President of North American Sales & Marketing
John Thomas	EVP, General Counsel & Corporate Secretary
Josh Suskin	Senior Director & Head of US Human Resources

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

KRYS Profile Financials

What are the risks of investing in KRYS? Is KRYS a good long-term investment? How much debt does KRYS have?